Auritec Pharmaceuticals Inc is a small company with operations in the US, Canada and Europe specializing in innovative, extended release drug delivery systems. Auritec was founded by Thomas J Smith, MD. Dr Smith was previously Medical Director and Chairman at Control Delivery Systems, Inc. (CDS), where he was the co-founder, PI on key patents and remains a significant shareholder. Auritec has developed a novel approach to small molecule extended release drug delivery with implications so far for the treatment of certain CNS, and certain hypertension indications, as well as for antibiotics effective against bioterrorism agents. Auritec’s primary objective is to develop and test the use of its Plexis(™) platform in a wide range of drug classes, and subsequently license the technology to key partners to continue development, trials and eventual commercialization.